サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765050

細胞溶解／細胞分画の世界市場

Cell Lysis / Cell Fractionation

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
細胞溶解／細胞分画の世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細胞溶解／細胞分画の世界市場は2030年までに49億米ドルに到達

2024年に36億米ドルと推定される細胞溶解／細胞分画の世界市場は、2024年から2030年にかけてCAGR 5.6%で成長し、2030年には49億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである哺乳類細胞は、CAGR6.5%を記録し、分析期間終了時には25億米ドルに達すると予測されます。微生物細胞セグメントの成長率は、分析期間でCAGR 5.1％と推定されます。

米国市場は9億5,830万米ドルと推定、中国はCAGR5.3％で成長予測

米国の細胞溶解／細胞分画市場は、2024年に9億5,830万米ドルと推定されます。世界第2位の経済大国である中国は、2024-2030年のCAGRを5.3%として、2030年までに7億7,460万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.2%と4.6%と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界の細胞溶解／細胞分画市場- 主要動向と促進要因のまとめ

細胞溶解は生物学的調査の解明に不可欠か？

細胞溶解は、タンパク質、DNA、RNA、細胞小器官などの内部内容物を放出するために細胞を破壊するために不可欠な、生物学研究における基礎技術です。このプロセスは、ゲノミクス、プロテオミクス、メタボロミクスを含む多くの実験ワークフローにおいて重要な最初のステップであり、細胞成分の分析は、生物学的プロセス、疾病メカニズム、治療標的を理解するために必要です。細胞溶解は、溶解される細胞の種類や下流の用途に応じて、機械的、化学的、または酵素的方法によって達成することができます。超音波処理やホモジナイゼーションなどの機械的方法は、細菌や植物細胞のような頑強な細胞タイプを破壊するためにしばしば使用され、リゾチーム処理のような酵素的アプローチは、よりデリケートなサンプルに一般的であり、繊細な生体分子の保存を保証します。細胞溶解の成否は、得られる細胞分画の品質に直接影響するため、適切な方法を選択することが極めて重要です。長年にわたり、溶解技術の革新は、細胞内容物の収量と純度を向上させてきました。これは、タンパク質精製や配列決定のための核酸抽出のような高精度のアプリケーションにおいて特に重要です。したがって、細胞破砕は、研究および工業的バイオ生産の両方において重要なツールであり続け、科学者は生命の内部構造を分子レベルで解剖し、理解することができます。

細胞分画はなぜ細胞内構造の研究に不可欠なのか？

細胞分画は、細胞溶解後に細胞成分を分離するプロセスであり、個々の細胞小器官や高分子の機能や構造を研究するために不可欠です。細胞を溶解した後、遠心分離などの分画技術を用いて、核、ミトコンドリア、小胞体、細胞質などの様々な細胞内成分を分離します。これは、エネルギー産生、タンパク質合成、アポトーシスなどの細胞プロセスを理解する上で特に重要であり、特定のオルガネラの役割を分離して調べる必要があります。超遠心分離と密度勾配分画の進歩により、これらの成分をより正確に分離することが可能になり、研究者は生化学的性質や相互作用を詳細に研究することができるようになりました。神経生物学やがん研究のように、細胞小器官の挙動が病気の進行や治療反応に大きく影響する分野では、細胞分画は不可欠です。さらに、細胞分画は医薬品の開発にも広く応用されています。細胞小器官を分離することで、科学者は薬物のメカニズムや代謝経路をより深く理解することができ、最終的にはより的を絞った治療法の開発につながるからです。サブセル分析の必要性が高まるにつれ、細胞分画は進化を続け、様々な生物医学分野における細胞成分の詳細な探索をサポートしています。

技術革新は細胞溶解と分画をどのように形成しているか？

技術革新は、細胞溶解と分画の状況を劇的に変化させ、これらのプロセスをより効率的、スケーラブル、かつ正確にしました。最も注目すべき進歩の一つは、ハイスループットの細胞溶解を可能にする自動化システムの開発であり、創薬やゲノム研究などの大規模研究におけるワークフローを合理化しています。これらの自動化システムは、人為的ミスを最小限に抑え、ばらつきを減少させる。これは、繊細なサンプルを扱う場合や、複数の実験にわたって一貫性が要求される場合に極めて重要です。さらに、エレクトロポレーションや圧力サイクリング技術など、新しい非機械的溶解技術が登場し、従来の方法に代わる優しい方法を提供し、タンパク質の変性や壊れやすい細胞成分への損傷のリスクを低減しています。これらの技術革新は、タンパク質の完全性を維持することが下流の分析に不可欠であるプロテオミクスにおいて特に価値があります。分画の面では、マイクロフルイディクスの進歩により、マイクロスケールで細胞成分をより正確に分離できるようになり、サンプルのロスが減り、分画の純度が向上しました。これにより、微量の細胞マテリアルを細心の注意を払って扱わなければならないシングルセル解析に新たな扉が開かれました。さらに、機械学習アルゴリズムを分画プロセスに組み込むことで、特定の細胞特性に基づいて分画結果を予測し、最適化する能力が向上しています。このような技術開発がこの分野を前進させ、細胞溶解と分画が分子生物学研究の最先端であり続けることを確実にしています。

何が細胞溶解・分画市場の成長を牽引しているのか？

細胞溶解・分画市場の成長は、バイオテクノロジーの進歩、個別化医療に対する需要の高まり、プロテオミクスとゲノミクス調査範囲の拡大など、いくつかの要因によって牽引されています。バイオ医薬品業界では、特にがんや神経変性疾患に対する標的療法の開発が続けられており、高精度の細胞溶解・分画ツールの必要性が飛躍的に高まっています。自動化されたハイスループット溶解システムなどの技術的進歩により、研究者は大量のサンプルを迅速かつ効率的に処理することが容易になりつつあり、これは創薬や臨床診断などの分野で極めて重要です。研究者が個々の細胞の内容物を分離して分析する必要がある単一細胞分析への注目の高まりも、より洗練された溶解・分画技術への需要を後押ししています。さらに、複雑な生物学的システムの理解におけるプロテオミクスの台頭は、タンパク質複合体を忠実に分離・保存できる高度な分画技術へのニーズを煽っています。患者やヘルスケアプロバイダーが、これらの技術が提供する詳細な細胞・分子データに依存する、より個別化された正確な治療選択肢を求めるようになり、消費者行動も一役買っています。さらに、製薬業界における生物製剤の生産と品質管理に関する規制要件は、医薬品製造プロセスが厳格な基準を満たすことを確実にするため、堅牢な細胞溶解・分画ソリューションの採用を促しています。これらの要因は、ライフサイエンス研究への投資の増加と相まって、今後数年間も細胞溶解・分画市場の成長を促進すると予想されます。

セグメント

コンポーネント（消耗品、機器）、タイプ（哺乳類細胞、微生物細胞、その他のタイプ）、エンドユーザー（研究所・研究所、製薬・バイオテクノロジー企業、その他のエンドユーザー）

調査対象企業の例

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica L.L.C.
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10947

Global Cell Lysis / Cell Fractionation Market to Reach US$4.9 Billion by 2030

The global market for Cell Lysis / Cell Fractionation estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Mammalian Cells, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Microbial Cells segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$958.3 Million While China is Forecast to Grow at 5.3% CAGR

The Cell Lysis / Cell Fractionation market in the U.S. is estimated at US$958.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$774.6 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Cell Lysis / Cell Fractionation Market - Key Trends and Drivers Summarized

How Is Cell Lysis Essential to Unlocking Biological Research?

Cell lysis is a foundational technique in biological research, essential for breaking open cells to release their internal contents, such as proteins, DNA, RNA, and organelles. This process is a critical first step in many experimental workflows, including genomics, proteomics, and metabolomics, where the analysis of cellular components is required to understand biological processes, disease mechanisms, and therapeutic targets. Cell lysis can be achieved through mechanical, chemical, or enzymatic methods, depending on the type of cells being lysed and the downstream application. Mechanical methods, such as sonication or homogenization, are often used to disrupt tougher cell types like bacterial or plant cells, while enzymatic approaches, like lysozyme treatment, are common for more delicate samples, ensuring the preservation of sensitive biomolecules. The success of cell lysis directly impacts the quality of the resulting cellular fractions, which makes choosing the appropriate method crucial. Over the years, innovations in lysis techniques have improved the yield and purity of cellular contents, which is particularly important in high-precision applications like protein purification and nucleic acid extraction for sequencing. Cell lysis, therefore, remains a vital tool in both research and industrial bioproduction, allowing scientists to dissect and understand the inner workings of life at a molecular level.

Why Is Cell Fractionation Crucial for Studying Subcellular Structures?

Cell fractionation, the process of separating cellular components after lysis, is indispensable for studying the function and structure of individual organelles and macromolecules. Once the cells have been lysed, fractionation techniques, such as centrifugation, are used to separate the various subcellular components like the nucleus, mitochondria, endoplasmic reticulum, and cytoplasm. This is particularly important in understanding cellular processes such as energy production, protein synthesis, and apoptosis, where the roles of specific organelles must be examined in isolation. Advances in ultracentrifugation and density gradient fractionation have enabled more precise isolation of these components, allowing researchers to study their biochemical properties and interactions in great detail. In fields like neurobiology and cancer research, where the behavior of cellular organelles can significantly influence disease progression and treatment responses, cell fractionation is essential. Moreover, cell fractionation has wide applications in the development of pharmaceuticals, as isolating organelles allows scientists to better understand drug mechanisms and metabolic pathways, ultimately guiding the development of more targeted therapies. As the need for subcellular analysis grows, cell fractionation continues to evolve, supporting the detailed exploration of cellular components in various biomedical fields.

How Are Technological Innovations Shaping Cell Lysis and Fractionation?

Technological innovations have dramatically transformed the landscape of cell lysis and fractionation, making these processes more efficient, scalable, and precise. One of the most notable advancements is the development of automated systems that allow for high-throughput cell lysis, streamlining workflows in large-scale studies such as drug discovery and genomic research. These automated systems minimize human error and reduce variability, which is crucial when working with sensitive samples or when consistency is required across multiple experiments. Additionally, novel non-mechanical lysis techniques, such as electroporation and pressure cycling technology, have emerged, offering gentler alternatives to traditional methods and reducing the risk of protein denaturation or damage to fragile cellular components. These innovations are particularly valuable in proteomics, where maintaining the integrity of proteins is critical for downstream analysis. On the fractionation front, advancements in microfluidics have enabled more precise separation of cellular components at the microscale, reducing sample loss and improving the purity of the fractions. This has opened new doors for single-cell analysis, where tiny amounts of cellular material must be handled with extreme care. Moreover, the integration of machine learning algorithms into fractionation processes is enhancing the ability to predict and optimize fractionation outcomes based on specific cellular characteristics. These technological developments are driving the field forward, ensuring that cell lysis and fractionation remain at the cutting edge of molecular biology research.

What Is Driving Growth in the Cell Lysis and Fractionation Market?

The growth in the cell lysis and fractionation market is driven by several factors, including advancements in biotechnology, rising demand for personalized medicine, and the expanding scope of proteomics and genomics research. As the biopharmaceutical industry continues to develop targeted therapies, particularly for cancer and neurodegenerative diseases, the need for high-precision cell lysis and fractionation tools has grown exponentially. Technological advancements, such as automated and high-throughput lysis systems, are making it easier for researchers to process large numbers of samples quickly and efficiently, which is critical in fields like drug discovery and clinical diagnostics. The increasing focus on single-cell analysis, where researchers need to isolate and analyze the contents of individual cells, is also driving demand for more sophisticated lysis and fractionation technologies. Additionally, the rise of proteomics in understanding complex biological systems is fueling the need for advanced fractionation techniques that can isolate and preserve protein complexes with high fidelity. Consumer behavior is also playing a role, as patients and healthcare providers push for more personalized and precise treatment options, which depend on the detailed cellular and molecular data that these technologies provide. Furthermore, regulatory requirements for biologics production and quality control in the pharmaceutical industry are encouraging the adoption of robust cell lysis and fractionation solutions to ensure that drug manufacturing processes meet stringent standards. These factors, coupled with increased investment in life sciences research, are expected to continue driving the growth of the cell lysis and fractionation market in the coming years.

SCOPE OF STUDY:

The report analyzes the Cell Lysis / Cell Fractionation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Consumables, Instruments); Type (Mammalian Cells, Microbial Cells, Other Types); End-Use (Research Laboratories & Institutes, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica L.L.C.
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Lysis / Cell Fractionation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Proteomics and Genomics Expands Market for Cell Lysis Solutions
    • Advancements in Non-Mechanical Lysis Technologies Propel Innovation in Cell Fractionation
    • Increasing Use of Cell Lysis in Drug Discovery Strengthens Market Growth
    • Growing Adoption of Cell Fractionation in Cancer Research Drives Demand for Advanced Lysis Techniques
    • Technological Innovations in Microfluidic-Based Lysis Create New Opportunities in Cell Fractionation
    • Expansion of Single-Cell Analysis Boosts the Need for Gentle and Precise Cell Lysis Methods
    • Rising Investment in Biopharmaceutical Research Fuels Growth in Cell Lysis Technologies
    • Growing Application of Cell Lysis in Protein Purification Accelerates Market Growth
    • Advances in Enzyme-Based Lysis Methods Drive Innovation in Cell Fractionation
    • Rising Demand for Efficient Organelle Isolation Techniques Expands Opportunities in Cell Fractionation
    • Emergence of Automated Lysis Systems Enhances Efficiency and Scalability in Research Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Mammalian Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Mammalian Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Microbial Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Microbial Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Cell Lysis / Cell Fractionation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cell Lysis / Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION